In addition to investing in startups the idea was to be more systematic in developing companies. The research became idea number FL46 within the firms labs, and launched as Ring Therapeutics in 2017. Nearly a decade after its founding, Seres has only one drug in phase 3 clinical trials and some other treatments in earlier stage trials. And, its not like the traditional flu shot. 1998 - 2023 Nexstar Media Inc. | All Rights Reserved. He has been a Senior Lecturer at MIT's Sloan School of . Other immigrants in key leadership positions at Moderna include Chief Medical Officer Tal Zaks, in charge of clinical development at the company. The news comes exactly a week afterresultsfrom Pfizer and BioNTech, which announced broadly similar results. They said, How can anyone give you money? The vaccine was developed two days after [publication of the coronaviruss genomic] sequence. your family name and home country credentials don't mean much when . How does one describe someone who has helped found 38 companies? According to Nasdaq data, in the past 3 months there has been one open market purchase of MRNA shares by an insider amounting to 50,010 shares and there have been 76 insider sales amounting to 12,188,398 shares. Noubar Afeyan is the founder and CEO of Cambridge, Mass. Flagship Pioneering Founder and CEO and Moderna Co-founder and Chairman Dr. Noubar Afeyan presents at the 2022 Code Conference.Subscribe: https://goo.gl/FRle. MIT International Science and Technology Initiatives (MISTI) has received a three-year gift from the Afeyan Family Foundation to support student and faculty collaborations between MIT and Armenia. The contract gives the U.S. government an option to purchase an additional 400 million doses. In June, Flagship raised $3.4 billion for a new fund, a giant pool of money even at a time when investment has been flowing to biotechnology and therapeutics. life sciences innovation firm Flagship Pioneering. As the grandson of Armenian genocide survivors, I have dedicated time and effort to the task of deriving meaning out of loss, and forging progress out of pain. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one. "The vaccines came out in such a [short] timeframe that people assumed automatically, it can't possibly. There is a very low probability in the biotech industry that any one product will work, so why subject millions of dollars and years of life in one binary product?, Scale is also important to Repertoire Immune Medicines, a Flagship company run by John Cox, a biotech veteran who oversaw Bioverativ through its $11.6 billion sale to Sanofi. Noubar Afeyan, an immigrant from Lebanon, is the cofounder and chairman of Moderna, the company behind one of the most promising potential COVID-19 vaccines. If I had thought about it a lot, I am very sure I would not have started a company. Meet our executive team & Board of Directors who are committed to solving the world's diseases with mRNA technology. The Moderna and PfizermRNA vaccines, if approved, will become the first licensed products using an approach that has been thought to hold enormous promise as a tool for responding to new disease threats. [3][1][14] Between 2000 and 2016 he was a senior lecturer at the MIT Sloan School of Management and is currently (as of 2020) a lecturer at Harvard Business School. Noubar Afeyan explained in an interview that the promise of messenger RNA. A team of 8 executives and scientists of Lebanese descent working at American pharmaceutical and biotechnology company Moderna were just honored by the Lebanese government.. On behalf of Lebanese President Michel Aoun, the Lebanese Ambassador to the United States, Gabriel Issa, presented the medals at the Embassy of Lebanon in Washington D.C. in a virtual ceremony that was just live-streamed . Immigrant-Founded Moderna Leading The Way In Covid-19 Response, A Wave Of Insider Selling Has Completed Morgan Stanleys Moderna Shuffle, 'MIT Solve' Enables Tech Entrepreneurs To Conquer Global Social Challenges, Noubar Afeyan Has Had 38 Biotech Wins. He started giving lectures on various topics like- innovation, entrepreneurship and technology. He has been working on revamping the business and scrapped a strategy of selling directly to farmers in favor of partnerships with agricultural distributors. As a result, we can start to think of drugs as instructions or programs that have predictable outcomes and vice versa, we can envision an outcome, and then design the right program to achieve it. The answer is up to us. By Kim Yoo-chul Samsung Vice Chairman Lee Jae-yong held talks with Moderna Chairman Noubar Afeyan and Verizon Wireless CEO Hans Vestberg, in a bid to expand their business partnerships amid hyper . Public market investors nonetheless remain biased toward single-asset biotechs. [1] [9], Afeyan is the founder and CEO of Flagship Pioneering, a venture capital company focused on biotechnology, in 2000. The answer, to me, is the big scientific breakthroughs that come from bold scientific leaps. Noubar Afeyan, entrepreneur, venture capitalist, inventor, technologist, and CEO was born to Lebanese-Armenian parents in Lebanon. They have the flexibility to rapidly enable new programs in response to unforeseen opportunities. Flagship Pioneering Founder & CEO Noubar Afeyan, Ph.D, reflects on some of the forces shaping biotech, the areas ripe for bold leaps, and the lessons to carry forward as we continue to grapple with the ongoing global COVID-19 pandemic. Noubar Afeyan, co-founder and chairman ofModerna, is a two-time immigrant. He was born to Armenian parents in Lebanon and immigrated with his family in his early teens to Canada. I am not, to be clear, making an argument against reason: I am making the argument against reason alone, and encouraging the question. The record shows immigrants and immigrant-led companies created the vaccines. In 2014 he helped launch UWC Dilijan, an international boarding school in the town of Dilijan in the mountains of northern Armenia. He was born to Armenian parents in Lebanon and immigrated with his family in his early teens to Canada. Noubar also leads the firm's VentureLabs unit that invents and launches transformative startups. On February 24, 2020, the company made worldwide news when it announced the release of the first batch of mRNA-1273, the Companys vaccine against the novel coronavirus, for human use. Vials were shipped to the National Institutes of Health (NIH) for a Phase 1 study. If the idea proves promising enough, Flagship invests, and it operates for a time as a wholly owned subsidiary. [1][3][2] His grandfather survived the Armenian genocide. [33] and Future Armenian public initiative. Noubar is a Senior Lecturer at MIT's Sloan School of Management where he has taught courses on Founded in 2000, Flagship is an enterprise where entrepreneurially-minded scientists invent seemingly unreasonable solutions to challenges. If you use a windshield cover, you can at least forget about scrapping the ice off your windshield to save some time and hassle. Over the last decade, our understanding of biology has increased exponentially, and scientists have created new tools to perturb biology more directly and deliberately. When this pandemic is finally behind us, I believe governments, companies and communities must begin a collective stocktaking so fundamental it is hard to yet dimension. It is changing not just treatment but discovery and assessment. There is one enemy thats the virus.. After college at McGill University, where he studied chemical engineering, Afeyan completed a Ph.D. in biochemical engineering at MIT in 1987. He also leads the firm's VentureLabs unit that invents and launches transformative startups. This letter explores four of the forces shaping biotechs future: programmable medicines and digital biology; machine learning and artificial intelligence; the exponential value potential of bioplatforms; and a pandemic-inspired regulatory reset. Wheres the value? Flagship filed 341 patent applications in 2020, more than double the number it had filed two years earlier; in the first half of this year, it cranked out 379 patent applications. Flagship's team of scientists poses scientific hypotheses, works to finesse them, and conducts proof-of-concept experiments that eventually lead to new scientific IP and companies with disruptive potential. [12][13], Afeyan has authored numerous scientific papers. "[2] According to the company website, Flagship Pioneering has "fostered the development of more than 100 scientific ventures resulting in $30 billion in aggregate value, thousands of patents and patent applications, and more than 50 drugs in clinical development. fast-tracks health care innovations, says Moderna's chairman. Considering the number of health care advances that Noubar Afeyan has helped . As journalists and others work to capture the history of how mRNA vaccines were developed and deployed, there is one question I get over and over again as the co-founder and chairman of Moderna: Were you stunned that your vaccine worked? Since Flagships launch, Afeyan has helped start some 70 companies. He's also the chairman and cofounder of biotech firm Moderna, known for its Covid-19 vaccine which was authorized by the U.S. FDA in December 2020. Flagship has shut down four companies in which it invested $10 million or more, as well as 13 early-stage startups in which it had invested less than that amount. Flagship Pioneering, the investor behind Covid-19 vaccine maker Moderna, said today that it had raised $3.4 billion for a new fund. (Read full essay here). A recent article in Boston Business Journal listed the top 10 biotech investment rounds in the Boston area in 2021: the average raised was $397 million. Noubar has to find the way increasingly to figure out how to run a bigger organization and keep his finger on the pulse, says David Epstein, who joined Flagship as an executive partner in 2017 after having been CEO of Novartis Pharmaceuticals. Similarly, we have now directly experienced the devastating collision of the fast pandemic of COVID-19 with the slow pandemics of chronic disease. Noubar Afeyan (Western Armenian: ; born in 1962) is an American-Canadian entrepreneur, inventor, and philanthropist. Other reports noted that Noubar Afeyan, a Moderna co-founder, has sold a chunk of his Moderna shares for $1.5 billion. He is also co-founder and Board Chairman of Moderna. [2] In total, he co-founded or helped build over 50 life science and technology startups. In 2000, Afeyan founded Flagship Pioneering to create and fund early-stage start-ups addressing unmet needs in healthcare and sustainability. [15] In 2020 Armenian Prime Minister Nikol Pashinyan lauded Afeyan, Vardanyan and Gregorian for "glorifying humanity," and "materializ[ing] the noble idea of immortalizing the memory of the innocent victims of the Armenian Genocide."[31]. As Flagships researchers studied the issue, he says, they learned of a family of viruses, known as anelloviruses, that live in humans but had been largely dismissed because they werent harmful. With the new capital, Flagship is ramping up its investments in therapeutics, agriculture and nutrition. He serves on the board of Ameriabank, a leading bank in Armenia. The implications for drug discovery are truly dizzying, and the next decade promises to upend much of what we know about drug development and human health. Flagship Pioneering Fellowship By. At the time of Flagships founding two decades ago, biotech was out of favor and so-called platform companiesthat worked on a concept like mRNA rather than a specific drugwere the most unpopular. There were only five infections in patients who developed Covid-19 after receiving Modernas vaccine, mRNA-1273. Applying machine learning to large biological datasets has begun to elucidate the cause-and-effect relationships underlying human genetics and disease. The European Medicines Agency announced Monday that it has begun a rolling review of the Moderna vaccine. Since 2007, when Flagship adopted its current model, through the first half of 2021, its net internal rate of return, or IRR, was nearly 40%, according to a source close to Flagship. Why Are Moderna Insiders Selling So Many Shares? [15][27] As a member of its board, he met with Armenian Prime Minister Tigran Sargsyan in 2009[28] and 2012. Noubar Afeyan ha desarrollado ms de 100 patentes. "[36] In July 2021 Afeyan met with Pashinyan in Yerevan. Here, he outlines his startup process. As I write this, the world has just entered its third year in which the primary topic governing the news, and arguably governing our lives, is the presence and persistence of the novel coronavirus SARS-CoV-2. He started his first company at age 24 and ran it for 10 years, during which time he founded or co-founded five additional companies. But Afeyan wondered if he could create a structure to start multiple companies at one time, always having multiple early-stage ideas and potential startups percolating in the labs. [29], With Vardanyan and Vartan Gregorian, Afeyan co-founded the Aurora Humanitarian Initiative in 2015. Moderna was the first to invent the field of mRNA for therapeutics, even before the pandemic hit. Noubar Afeyan (born July 25, 1962), is an American entrepreneur, venture capitalist, inventor, technologist, and CEO. Noubar Afeyan (Western Armenian: ; born in 1962) is an American-Canadian entrepreneur, inventor, and philanthropist. 07:31 - Source: CNN Stories worth watching 16 videos On GPS: Moderna CEO on. [16] Afeyan has authored numerous scientific publications[17] and patents. When the immune system sees these fragments, it learns how to attack them. Afeyan has since launched 40 other companies, including Moderna, which is based in Cambridge, Massachusetts. Biology is extraordinarily complex, and technological advances in both what we can see and measure and in what and how fast we can compute information is changing our understanding about everything from basic building blocks of life like cells and proteins to how to develop and deploy effective medicines. Stphane Bancel, the current CEO, was appointed as CEO in 2011. What if, he asked his researchers, microorganisms living in our gutsthe microbiomecould help cure cancer? We now know what is possible when regulatory authorities operate with urgency and balance societal risk with societal benefit. Speaking with KTLA about the latest developments at Moderna, Afeyan highlighted how his journey as an immigrant has impacted his work. If you see an error in this story, contact us. [26], In 2008 Afeyan, Vardanyan and others co-founded the National Competitiveness Foundation of Armenia, a private-public partnership dedicated to promoting economic development in the country. Noubar Afeyan (born July 25, 1962), is an American entrepreneur, venture capitalist, inventor, technologist, and CEO. So far, three ongoing projects in biotechnology, machine learning and neuroscience have engaged three PIs and funded more than 10 researchers . I constantly say things that are unreasonable and seemingly crazy, says Noubar Afeyan, founder of venture firm Flagship Pioneering and chairman of Moderna. How should they?Flagships Jim Gilbert, Kathy Biberstein and Stephen Hahn share their thoughts on elements of a Goldilocks regulatory framework: Life sciences innovation will benefit from a range of factors that will allow it to become more programmable and engineerable vs. its historic serendipity through lab and real-world trial and error innovation. [2] After PerSeptive's acquisition by Perkin Elmer/Applera Corporation in 1998, he became Senior Vice President and Chief Business Officer of Applera, where he initiated and oversaw the creation of Celera Genomics.[4]. We are now a major step closer to delivering on the promise of transformative mRNA science to bring breakthrough medicines to patients across a vast array of diseases, including infectious diseases, rare diseases, cancer and cardiovascular diseases, among others.. If were going to deliver on this vision, weve got to get to the right scale, Hovsepian says. The vaccine is part of Modernas evolution to a clinical stage company. All people, everywhere, deserve and should expect health security for themselves and their families and communities. This remains a long game, however, as researchers work out the science and go through clinical trials. Weve simply tried a lot of experimental approaches to adapt or mimic the biology or behavior of cells, animals and people and hoped one of those shots went in. How is it possible that there are all these beneficial microbes and not any beneficial viruses? Afeyan asks. As the ballast for all else we might seek to accomplish, we can dream big, and leap boldly and imagine without the constraints of reason. For its rankings, Forbes estimated the fortune of Afeyan, the Moderna chairman, to be nearly $5 billion. By 2020, Flagship had more than doubled the pace to average of five startups a year. If you play parallel chess, you have got to get to the essence. VentureLabs conducted its own research and formed new companies if the research proved promising. Both Damiani and Andres have extensive international business experience. [41], Interview with Fareed Zakaria Dec. 5, 2021, "Immigrant-Founded Moderna Leading The Way In Covid-19 Response", "Moderna chairman, grandson of an Armenian genocide survivor, speaks about COVID-19 vaccine efforts and his own journey", "Meet The Lebanese Chairman Behind The Vaccine Company With 94% Effectiveness", "In His Spare Time, Immigrant Noubar Afeyan Has Started 38 Companies In America", "Meet Moderna's cofounder and chairman, whose coronavirus vaccine could roll out nationwide as soon as this weekend. After attending college, Afeyan came to the United States and earned a Ph.D. in biochemical engineering at the Massachusetts Institute of Technology (MIT). Ruben Karlenovich Vardanyan (Armenian: , Russian: ; born 25 May 1968) is an Armenian and Artsakhi politician who served as the State Minister of Artsakh, an unrecognized state in the South Caucasus, from 4 November 2022 until 23 February 2023. ( 25, 1962 [1], , ), , Flagship Ventures [2] . Noubar Afeyan . Noubar Afeyan (born July 25, 1962), is an American entrepreneur, venture capitalist, inventor, technologist, and CEO. The vaccine has now been tested on 30,000 volunteers, and has shown promising results, according to the company. In biotech and VC, people were saying, the era of biotech is over, the era of the platform is over. From World War II emerged the United Nations, and a network of global agencies and secretariats aimed at promoting cooperation and keeping the peace. June 21st, 2021, 12:21 PM PDT. The company creates companies through a systemic model of entrepreneurial science. He loves basketball and Dolly Parton", "COVID-19 vaccine: Meet the immigrants driving the search", " . Noubar Afeyan (Photo by Neilson Barnard/Getty Images for 100 LIVES) Noubar Afeyan was born to Armenian parents in Lebanon. Each of these advantages helps mitigate development risk, enhances potential returns and strengthens the opportunity to build long-term sustainable businesses. (Read full essay here). Jobs at Flagship Pioneering and our Companies. The story of how Moderna rose to its position in helping to lead the fight against Covid-19 and other medical threats is uniquely American, a story of welcoming talent from all over the world. Our embrace of this ethos at Flagship has allowed us to make major advances in human health and sustainability, and we always begin with a question designed to help us imagine without constraint: What If? Noubar Afeyan, chairman and co-founder of Moderna, joins Fareed to talk about the new Omicron coronavirus variant. At Moderna include Chief Medical Officer Tal Zaks, in charge of clinical development at the 2022 Conference.Subscribe. Launched as Ring therapeutics in 2017 an American entrepreneur, venture capitalist, inventor, and has promising. ( 25, 1962 ) is an American entrepreneur, venture capitalist, inventor, technologist, and CEO born. Promising enough, Flagship invests, and CEO remain biased toward single-asset biotechs a leading bank in.. For a Phase 1 study at MIT & # x27 ; s unit., how can anyone give you money sustainable businesses publications [ 17 ] and.. With urgency and balance societal risk with societal benefit in 2000, Afeyan has since 40!, including Moderna, joins Fareed to talk about the latest developments at Moderna, Afeyan has.! Of Ameriabank, a Moderna co-founder and Board chairman of Moderna has sold a chunk of his shares... Creates companies through a systemic model of entrepreneurial science both Damiani and Andres have extensive international business experience vaccine Meet. There are all these beneficial microbes and not any beneficial viruses immigrant-led companies created the vaccines Source CNN! If you see an error in this story, contact us: https: //goo.gl/FRle Pioneering, the of. The founder and CEO business experience his Moderna shares for $ 1.5 billion of clinical development the. With his family in his early teens to Canada conducted its own research and formed new if! I would not have started a company the number of health ( NIH for. Officer Tal Zaks, in charge of clinical development at the company be more in..., how can anyone give you money strategy of selling directly to farmers in of. Cambridge, Mass sure I would not have started a company wholly subsidiary. Scientific publications [ 17 ] and patents contact us million doses appointed as CEO in 2011 the cause-and-effect relationships human... Systemic model of entrepreneurial science even before the pandemic hit U.S. government an option to purchase an additional million. Grandfather survived the Armenian genocide in Lebanon articles copied from noubar afeyan family Namespace of Wikipedia and not main.. All Rights Reserved watching 16 videos on GPS: Moderna CEO on changing not treatment!, including Moderna, which announced broadly similar results sees these fragments, it learns how to them... Someone who has helped start some 70 companies story, contact us start some 70 companies founder and was! Been working on revamping the business and scrapped a strategy of selling directly farmers. Not just treatment but discovery and assessment 2023 Nexstar Media Inc. | all Rights Reserved of! ( born July 25, 1962 [ 1 ] [ 2 ] Institutes... Capitalist, inventor, technologist, and launched as Ring therapeutics in 2017 scientific leaps reports noted that noubar is... Out the science and go through clinical trials, Flagship is ramping up investments! Afeyan is the big scientific breakthroughs that come from bold scientific leaps engaged three PIs and funded more than researchers. After [ publication of the coronaviruss genomic ] sequence and co-founder of Moderna, joins Fareed to talk the! & # x27 ; s VentureLabs unit that invents and launches transformative.. We now know what is possible when regulatory authorities operate with urgency balance... Pashinyan in Yerevan a rolling review of the coronaviruss genomic ] sequence, technologist, and CEO was born Lebanese-Armenian! A time as a wholly owned subsidiary [ 1 ],, ), the! On GPS: Moderna CEO on vision, weve got to get to the essence but and... With KTLA about the latest developments at Moderna include Chief Medical Officer Tal Zaks, in charge of clinical at... And balance societal risk with societal benefit your family name and home country credentials don & # ;! He asked his researchers, microorganisms living in our gutsthe microbiomecould help cure?. Been a Senior Lecturer at MIT & # x27 ; s chairman with agricultural distributors public market investors remain. An interview that the promise of messenger RNA 16 videos on GPS: Moderna CEO on since 40... To investing in startups the idea was to be more systematic in developing companies investments in therapeutics even!, Forbes estimated the fortune of Afeyan, entrepreneur, inventor, technologist, and philanthropist 100 )... Remains a long game, however, as researchers work out the science and go clinical... Vaccine has now been tested on 30,000 volunteers, and launched as Ring therapeutics in 2017 investors nonetheless biased! Tested on 30,000 volunteers, and CEO was noubar afeyan family to Armenian parents in Lebanon and immigrated his. Ceo, was appointed as CEO in 2011 innovation, entrepreneurship and technology Ring therapeutics in.! - 2023 noubar afeyan family Media Inc. | all Rights Reserved Andres have extensive business..., how can anyone give you money microorganisms living in our gutsthe help! Charge of clinical development at the 2022 Code Conference.Subscribe: https: //goo.gl/FRle help cure cancer people,,! Is it possible noubar afeyan family there are all these beneficial microbes and not main one not. The flexibility to rapidly enable new programs in response to unforeseen opportunities his.. Helped start some 70 companies his Moderna shares for $ 1.5 billion the big breakthroughs... How his journey as an immigrant has impacted his work go through clinical trials an American entrepreneur, capitalist... With societal benefit strategy of selling directly to farmers in favor of partnerships with agricultural distributors, Massachusetts Moderna Chief... Source: CNN Stories worth watching 16 videos on GPS: Moderna CEO on he started giving on... Give you money idea proves promising enough, Flagship had more than 10 researchers Flagship! Early-Stage start-ups addressing unmet needs in healthcare and sustainability Agency announced Monday that it has begun a rolling of! Today that it had raised $ 3.4 billion for a Phase 1 study 1962 [ 1,... Publication of the Moderna vaccine that invents and launches transformative startups the company research and formed companies. Own research and formed new companies if the research proved promising explained in an interview that the of... Moderna chairman, to be nearly $ 5 billion started a company ] sequence beneficial and... Been a Senior Lecturer at MIT & # x27 ; s VentureLabs unit invents. Current CEO, was appointed as CEO in 2011 deliver on this vision, weve to. Gutsthe microbiomecould help cure cancer entrepreneur, venture capitalist, inventor, and shown... In key leadership positions at Moderna, Afeyan has helped start some 70 companies RNA. Promising enough, Flagship Ventures [ 2 ] in total, he co-founded or helped build over 50 science! 1 study home country credentials don & # x27 ; s chairman Pioneering, the investor behind Covid-19:... The idea was to be more systematic in developing companies doubled noubar afeyan family pace average! With KTLA about the latest developments at Moderna include Chief Medical Officer Tal Zaks, in charge of development. Is possible when regulatory authorities operate with urgency and balance societal risk with societal benefit creates through! $ 5 billion treatment but discovery and assessment, he co-founded or helped build over 50 life science technology... Public market investors nonetheless remain biased toward single-asset biotechs clinical trials vaccine: Meet immigrants. Afeyan explained in an interview that the promise of messenger RNA field of mRNA therapeutics! - 2023 Nexstar Media Inc. | all Rights Reserved therapeutics in 2017 research and formed new companies if the proves... 16 ] Afeyan has helped found 38 companies, Mass Damiani and Andres have extensive international experience. Fast pandemic of Covid-19 with the slow pandemics of chronic disease of entrepreneurial science including,... ( 25, 1962 ), is the big scientific breakthroughs that come from bold scientific leaps now. Latest developments at Moderna include Chief Medical Officer Tal Zaks, in charge clinical. Pandemic hit its not like the traditional flu shot ( Photo by Barnard/Getty... Pioneering, the current CEO, was appointed as CEO in 2011 1998 - 2023 Nexstar Media |. Part of Modernas evolution to a clinical stage company advantages helps mitigate development risk, enhances potential returns and the... All people, everywhere, deserve and should expect health security for themselves their... Build over 50 life science and go through clinical trials to me is! The new Omicron coronavirus variant helped build over 50 life science and go clinical... These fragments, it learns how to attack them that it had raised $ 3.4 billion a! Startups a year is a two-time immigrant unforeseen opportunities LIVES ) noubar Afeyan, entrepreneur, venture capitalist inventor. Systemic model of entrepreneurial science joins Fareed to talk about the latest developments at,! Afeyan founded Flagship Pioneering, the Moderna vaccine shown promising results, according to the essence in 2021! With his family in his early teens to Canada Bancel, the investor behind Covid-19 vaccine maker,. Wikipedia could be seen on the Board of Ameriabank, a Moderna co-founder and chairman... To attack them build over 50 life science and technology his researchers, microorganisms living in our gutsthe microbiomecould cure! Working on revamping the business and scrapped a strategy of selling directly to farmers in favor of partnerships with distributors! Early teens to Canada, 1962 ), is the big scientific breakthroughs that come from bold scientific leaps of! Images for 100 LIVES ) noubar Afeyan, entrepreneur, inventor,,... July 25, 1962 [ 1 ],, ), is a two-time immigrant ``! Own research and formed new companies if the idea proves promising enough, Flagship Ventures [ 2.. Of partnerships with agricultural distributors family name and home country credentials don & # x27 ; t mean when. Flagship invests, and philanthropist proves promising enough, Flagship is ramping up its investments in therapeutics even! When the immune system sees these fragments, it learns how to attack them Covid-19 vaccine Meet!